Serum and mucosal antibody responses to pneumococcal protein antigens in children: Relationships with carriage status

European Journal of Immunology

Volumn 36, Issue 1, 2006, Pages 46-57

  Zhang, Qibo ^a   Bernatoniene, Jolanta ^a   Bagrade, Linda ^a   Pollard, Andrew J ^b   Mitchell, Timothy J ^c   Paton, James C ^d   Finn, Adam ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antibodies; Bacterial infection; Immune responses; Mucosal immunology; Vaccines

Indexed keywords

ADHESIN; ANTIBODY; BACTERIAL ANTIGEN; BINDING PROTEIN; CHOLINE; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; PNEUMOLYSIN; RECOMBINANT PROTEIN;

ADENOIDECTOMY; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOOD ANALYSIS; CELL CULTURE; CELL FUNCTION; CHILD; CHILD CARE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE CARRIER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SALIVA ANALYSIS; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE;

ADENOIDS; AGE FACTORS; ANTIBODIES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NASOPHARYNX; RESPIRATORY MUCOSA; SALIVA; STREPTOCOCCUS PNEUMONIAE;

EID: 30944453015     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535101     Document Type: Article

References (51)

1. Siber, G. R., Pneumococcal disease: prospects for a new generation of vaccines. Science 1994. 265: 1385-1387.
2. Klugman, K. P., Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect. Dis. 2001. 1: 85-91.
3. Brooks-Walter, A., Briles, D. E. and Hollingshead, S. K., The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 1999. 67: 6533-6542.
4. Hammerschmidt, S., Talay, S. R., Brandtzaeg, P. and Chhatwal, G. S., SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 1997. 25: 1113-1124.
5. Janulczyk, R., Iannelli, F., Sjoholm, A. G., Pozzi, G. and Bjorck, L., Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 2000. 275: 37257-37263.
6. Rosenow, C., Ryan, P., Weiser, J. N., Johnson, S., Fontan, P., Ortqvist, A. and Masure, H. R., Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 1997. 25: 819-829.
7. Paton, J. C., Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol. 1998. 6: 85-87.
8. Morrison, K. E., Lake, D., Crook, J., Carlone, G. M., Ades, E., Facklam, R. and Sampson, J. S., Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J. Clin. Microbiol. 2000. 38: 434-437.
9. Alexander, J. E., Lock, R. A., Peeters, C. C., Poolman, J. T., Andrew, P. W., Mitchell, T. J., Hausman, D. and Paton, J. C., Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 1994. 62: 5683-5688.
10. Briles, D. E., Hollingshead, S., Brooks-Walter, A., Nabors, G. S., Ferguson, L., Schilling, M., Gravenstein, S. et al. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 2000. 18: 1707-1711.
11. Briles, D. E., Ades, E., Paton, J. C., Sampson, J. S., Carlone, G. M., Huebner, R. C., Virolainen, A. et al., Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 2000. 68: 796-800.
12. Simell, B., Korkeila, M., Pursiainen, H., Kilpi, T. M. and Kayhty, H., Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein A in children. J. Infect. Dis. 2001. 183: 887-896.
13. Rapola, S., Jantti, V., Haikala, R., Syrjanen, R., Carlone, G., Sampson, J. S., Briles, D. E. et al., Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J. Infect. Dis. 2000. 182: 1146-1152.
14. Virolainen, A., Russell, W., Crain, M. J., Rapola, S., Kayhty, H. and Briles, D. E., Human antibodies to pneumococcal surface protein A in health and disease. Pediatr. Infect. Dis. J 2000. 19: 134-138.
15. Aniansson, G., Alm, B., Andersson, B., Larsson, P., Nylen, O., Peterson, H., Rigner, P. et al., Nasopharyngeal colonization during the first year of life. J. Infect. Dis. 1992. 165 Suppl 1: S38-S42.
16. Faden, H., Duffy, L., Wasielewski, R., Wolf, J., Krystofik, D. and Tung, Y., Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J. Infect. Dis. 1997. 175: 1440-1445.
17. Greenwood, B., The epidemiology of pneumococcal infection in children in the developing world. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999. 354: 777-785.
18. Gray, B. M., Converse, G. M. and Dillon, H. C. Jr., Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 1980. 142: 923-933.
19. McCool, T. L., Cate, T. R., Moy, G. and Weiser, J. N., The immune response to pneumococcal proteins during experimental human carriage. J. Exp. med. 2002. 195: 359-365.
20. McCool, T. L., Cate, T. R., Tuomanen, E. I., Adrian, P., Mitchell, T. J. and Weiser, J. N., Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect. Immun. 2003. 71: 5724-5732.
21. Rapola, S., Kilpi, T., Lahdenkari, M., Takala, A. K., Makela, P. H. and Kayhty, H., Do antibodies to pneumococcal surface adhesin A prevent pneumococcal involvement in acute otitis media? J. Infect. Dis. 2001. 184: 577-581.
22. Rapola, S., Jantti, V., Eerola, M., Makela, P. H., Kayhty, H. and Kilpi, T., Anti-PsaA and the risk of pneumococcal AOM and carriage. Vaccine 2003. 21: 3608-3613.
23. Lipsitch, M., Whitney, C. G., Zell, E., Kaijalainen, T., Dagan, R. and Malley, R., Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS.med. 2005. 2: e15.
24. Russell, M. W., Moldoveanu, Z., White, P. L., Sibert, G. J., Mestecky, J. and Michalek, S. M., Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 1996. 64: 1272-1283.
25. Lynch, J. M., Briles, D. E. and Metzger, D. W., Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect. Immun. 2003. 71: 4780-4788.
26. Kurono, Y., Yamamoto, M., Fujihashi, K., Kodama, S., Suzuki, M., Mogi, G., McGhee, J. R. and Kiyono, H., Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J. Infect. Dis. 1999. 180: 122-132.
27. van Kempen, M. J., Rijkers, G. T. and Van Cauwenberge, P. B., The immune response in adenoids and tonsils. Int. Arch. Allergy Immunol. 2000. 122: 8-19.
28. Zhang, Q., Choo, S. and Finn, A., Immune responses to novel pneumococcal proteins (pneumolysin, PspA, PsaA and CbpA) in adenoidal B cells from children. Infect. Immun. 2002. 70: 5363-5369.
29. Hendley, J. O., Sande, M. A., Stewart, P. M. and Gwaltney, J. M., Jr., Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J. Infect. Dis. 1975. 132: 55-61.
30. Loda, F. A., Collier, A. M., Glezen, W. P., Strangert, K., Clyde, W. A. Jr. and Denny, F. W., Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J. Pediatr. 1975. 87: 1087-1093.
31. Lakshman, R., Murdoch, C., Race, G., Burkinshaw, R., Shaw, L. and Finn, A., Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch. Dis. Child. 2003. 88: 211-214.
32. Laine, C., Mwangi, T., Thompson, C. M., Obiero, J., Lipsitch, M. and Scott, J. A., Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal Kenya. Infect. Immun. 2004. 72: 3331-3335.
33. Obaro, S. K., Adegbola, R. A., Tharpe, J. A., Ades, E. W., McAdam, K. P., Carlone, G. and Sampson, J. S., Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants. Vaccine 2000. 19: 411-412.
34. Zhang, Q., Choo, S., Everard, J., Jennings, R. and Finn, A., Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect. Immun. 2000. 68: 2692-2697.
35. Ivarsson, M., Quiding-Jarbrink, M. and Lundberg, C., Immunoglobulin-secreting cells in the surface secretion on the pharyngeal tonsils. Acta Otolaryngol. (Stockh) 1999. 119: 939-943.
36. Ivarsson, M., Lundberg, C. and Quiding-Jarbrink, M., Antibody production directed against pneumococci by immunocytes in the adenoid surface secretion. Int. J. Pediatr. Otorhinolaryngol. 2004. 68: 537-543.
37. Boyaka, P. N., Wright, P. F., Marinaro, M., Kiyono, H., Johnson, J. E., Gonzales, R. A., Ikizler, M. R. et al., Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am. J. Pathol. 2000. 157: 2023-2035.
38. French, M. A., Denis, K. A., Dawkins, R. and Peter, J. B., Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4. Clin. Exp. Immunol. 1995. 100: 47-53.
39. Bardardottir, E., Jonsson, S., Jonsdottir, I., Sigfusson, A. and Valdimarsson, H., IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J. Infect. Dis. 1990. 162: 482-488.
40. Brandtzaeg, P., Immunology of tonsils and adenoids: everything the ENT surgeon needs to know [erratum appears in Int. J. Pediatr. Otorhinolaryngol 2004. 68: 387]. Int. J. Pediatr Otorhinolaryngol. 2003. 67 Suppl 1: S69-S76.
41. Johansen, F. E., Baekkevold, E. S., Carlsen, H. S., Farstad, I. N., Soler, D. and Brandtzaeg, P., Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 2005. 106: 593-600.
42. O'Brien, K. L., Bronsdon, M. A., Dagan, R., Yagupsky, P., Janco, J., Elliott, J., Whitney, C. G. et al., Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J. Clin. Microbiol. 2001. 39: 1021-1024.
43. Berry, A. M., Yother, J., Briles, D. E., Hansman, D. and Paton, J. C., Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 1989. 57: 2037-2042.
44. Hill, J., Andrew, P. W. and Mitchell, T. J., Amino acids in pneumolysin important for hemolytic activity identified by random mutagenesis. Infect. Immun. 1994. 62: 757-758.
45. Korchev, Y. E., Bashford, C. L., Pederzolli, C., Pasternak, C. A., Morgan, P. J., Andrew, P. W. and Mitchell, T. J., A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem. J. 1998. 329: 571-577.
46. Ogunniyi, A. D., Woodrow, M. C., Poolman, J. T. and Paton, J. C., Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 2001. 69: 5997-6003.
47. Ogunniyi, A. D., Folland, R. L., Briles, D. E., Hollingshead, S. K. and Paton, J. C., Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 2000. 68: 3028-3033.
48. Pilling, P. A., Lawrence, M. C., Berry, A. M., Ogunniyi, A. D., Lock, R. A. and Paton, J. C., Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae. Acta Crystallogr. D Biol. Crystallogr. 1998. 54: 1464-1466.
49. Paton, J. C., Lock, R. A., Lee, C. J., Li, J. P., Berry, A. M., Mitchell, T. J., Andrew, P. W. et al., Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 1991. 59: 2297-2304.
50. Hartmann, G. and Krieg, A. M., Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 2000. 164: 944-953.
51. Dowes, C., Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J. Dent. Res. 1987. 66: 648-653.